Recce Pharmaceuticals (RCE.AX) Stock Price
Recce Pharmaceuticals Price
Over the last 12 years Recce Pharmaceuticals grew revenue by 127.7% annually, reaching 7.51 M AUD. For Recce Pharmaceuticals, the net margin of -285.4% is up versus -825.3% a few years ago. The stock trades about 3% above its 52-week low.
Recce Pharmaceuticals stock price
Recce Pharmaceuticals business model & stock analysis
Frequently asked questions about Recce Pharmaceuticals
Converted at the current exchange rate, the Recce Pharmaceuticals share trades at 0.20 EUR (0.33 AUD).
The Recce Pharmaceuticals share (RCE.AX) is listed on 3 stock exchanges, including: ASX (RCE.AX), Frankfurt (R9Q.F), München (R9Q.MU).
No history available for Recce Pharmaceuticals.
The revenue cannot currently be calculated for Recce Pharmaceuticals.
The profit of Recce Pharmaceuticals is -14.96 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Recce Pharmaceuticals is currently -6.38. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Recce Pharmaceuticals stock.
The P/S cannot be calculated for Recce Pharmaceuticals currently.
The Eulerpool Quality Score for Recce Pharmaceuticals is 2/10.
The ISIN of Recce Pharmaceuticals is AU000000RCE5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Recce Pharmaceuticals is A2ADQM. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Recce Pharmaceuticals is RCE.AX. The ticker symbol is used to trade Recce Pharmaceuticals shares on the stock exchange.
Recce Pharmaceuticals paid dividends every year for the past 0 years.
Recce Pharmaceuticals is assigned to the 'Health' sector.
The dividends of Recce Pharmaceuticals are distributed in AUD.
Recce Pharmaceuticals stock
Recce Pharmaceuticals Peer Group
Recce Pharmaceuticals Ticker
Recce Pharmaceuticals FIGI
All fundamentals and in-depth analysis of Recce Pharmaceuticals
Our stock analysis for Recce Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recce Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.